» Authors » Blanca Espinet

Blanca Espinet

Explore the profile of Blanca Espinet including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 157
Citations 1909
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Montesdeoca S, Garcia-Gisbert N, Calvo X, Arenillas L, Roman D, Fernandez-Rodriguez C, et al.
Cancers (Basel) . 2023 Aug; 15(16). PMID: 37627180
Waldenström Macroglobulinemia (WM) is a lymphoplasmacytic lymphoma with bone marrow (BM) involvement and IgM monoclonal gammopathy. To date, no studies have focused specifically on peripheral blood (PB) involvement. In this...
12.
Carbo-Meix A, Guijarro F, Wang L, Grau M, Royo R, Frigola G, et al.
Haematologica . 2023 Aug; 109(2):493-508. PMID: 37560801
The t(14;19)(q32;q13) often juxtaposes BCL3 with immunoglobulin heavy chain (IGH) resulting in overexpression of the gene. In contrast to other oncogenic translocations, BCL3 rearrangement (BCL3-R) has been associated with a...
13.
Cabrera-Serrano A, Sanchez-Maldonado J, Ter Horst R, Macauda A, Garcia-Martin P, Benavente Y, et al.
Int J Mol Sci . 2023 May; 24(9). PMID: 37175717
Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults worldwide. Although genome-wide association studies (GWAS) have uncovered the germline genetic component underlying CLL susceptibility, the potential use of...
14.
Mansouri L, Thorvaldsdottir B, Sutton L, Karakatsoulis G, Meggendorfer M, Parker H, et al.
Leukemia . 2023 Jan; 37(2):504. PMID: 36635392
No abstract available.
15.
Carrillo-Tornel S, Chen-Liang T, Zurdo M, Puiggros A, Gomez-Llonin A, Garcia-Malo M, et al.
Br J Haematol . 2022 Dec; 201(3):470-479. PMID: 36573331
Studies prior to next-generation sequencing (NGS) showed that the frequent indolent course of chronic lymphocytic leukaemia (CLL) is related to most cells remaining quiescent in the G -G cell cycle...
16.
Mansouri L, Thorvaldsdottir B, Sutton L, Karakatsoulis G, Meggendorfer M, Parker H, et al.
Leukemia . 2022 Dec; 37(2):339-347. PMID: 36566271
Recent evidence suggests that the prognostic impact of gene mutations in patients with chronic lymphocytic leukemia (CLL) may differ depending on the immunoglobulin heavy variable (IGHV) gene somatic hypermutation (SHM)...
17.
Flores-Moran M, Rodriguez-Sevilla J, Arenillas L, Calvo X, Puiggros A, Espinet B, et al.
Int J Lab Hematol . 2022 Dec; 45(3):e55-e59. PMID: 36513944
No abstract available.
18.
Antic D, Milic N, Chatzikonstantinou T, Scarfo L, Otasevic V, Rajovic N, et al.
J Hematol Oncol . 2022 Aug; 15(1):116. PMID: 36028857
Background: Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to COVID-19 related poor outcomes, including thrombosis and death, due to the advanced age, the presence of comorbidities, and...
19.
Ramos-Campoy S, Puiggros A, Kamaso J, Bea S, Bougeon S, Larrayoz M, et al.
Cancers (Basel) . 2022 Aug; 14(15). PMID: 35954380
Chromothripsis (cth) has been associated with a dismal outcome and poor prognosis factors in patients with chronic lymphocytic leukemia (CLL). Despite being correlated with high genome instability, previous studies have...
20.
Puiggros A, Ramos-Campoy S, Kamaso J, de la Rosa M, Salido M, Melero C, et al.
Cancers (Basel) . 2022 Jul; 14(14). PMID: 35884436
Novel treatments in chronic lymphocytic leukemia (CLL) have generated interest regarding the clinical impact of genomic complexity, currently assessed by chromosome banding analysis (CBA) and chromosomal microarray analysis (CMA). Optical...